Asembia

Asembia announced a leadership change on October 29, 2026. Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.

What changed

David Skomo was named Chief Executive Officer. Skomo succeeds Lawrence Irene, co-founder of Asembia.

• Leader: David Skomo
• Role: Chief Executive Officer
• Effective: Not specified in the announcement
• Announcement date: October 29, 2026

Leadership background

Skomo brings more than three decades of specialty pharmacy, PBM, and pharma services experience and joined Asembia from WellDyne, where he most recently served as Chief Operating Officer and Division President of HealthDyne. In that role he oversaw home delivery pharmacy, specialty pharmacy services, PBM operations, customer care, and HealthDyne sales and client services. He previously held senior positions at OptumRx, CVS, and Diplomat.

The mandate

Asembia said Skomo will focus on strengthening and investing in the company’s commercial capabilities, technology platform, and pharmacy services through both organic growth and strategic acquisitions.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: Asembia leadership announcement.